Technology Assisted Physical Activity Among Hospitalised Medical Patients
Launched by MARIUS HENRIKSEN · Sep 14, 2020
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
The study will be conducted as a quasi-randomised trial using a large tertiary public hospital in Copenhagen, Denmark. Patients admitted to Department of Respiratory Medicine (2 wards), Department of Cardiology, and Department of Geriatrics will be included, and they will have their physical activity level measured either with or without a bedside monitor providing visual feedback of time spent bedridden, sitting, standing and walking.
All participants will have their physical activity measured during hospitalisation. Approximately half of the participants will receive visual feedback abou...
Gender
ALL
Eligibility criteria
- • INCLUSION CRITERIA
- An individual will be eligible for study participation if he/she meets the following criteria:
- • 1. Is admitted to one of the participating departments
- • 2. Has signed informed consent
- • 3. Reads and speaks Danish
- • EXCLUSION CRITERIA
- An individual will be excluded from the study if he/she meets any of the following criteria:
- • 1. Any condition that, in the opinion of the investigator, makes the person unfit for participation
- • 2. Expected hospitalisation less than 24 hours
- • 3. Has no independent ambulatory abilities (e.g. wheel chair user)
- • 4. Needs personal assistance in body transfers and ambulation (Cumulated Ambulation Score 0, 1, 2, or 3)
- • 5. Has allergy towards band aid
About Marius Henriksen
Marius Henriksen is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to improving patient outcomes, the organization collaborates with leading healthcare professionals and institutions to design, implement, and oversee clinical trials across various therapeutic areas. Marius Henriksen prioritizes ethical standards and regulatory compliance, ensuring that all studies are conducted with the highest level of integrity and respect for participant welfare. By leveraging cutting-edge methodologies and rigorous scientific protocols, the organization aims to contribute valuable insights to the medical community and foster the development of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials